Cargando…
Obeticholic Acid Protects against Gestational Cholestasis-Induced Fetal Intrauterine Growth Restriction in Mice
Gestational cholestasis is a common disease and is associated with adverse pregnancy outcomes. However, there are still no effective treatments. We investigated the effects of obeticholic acid (OCA) on fetal intrauterine growth restriction (IUGR) during 17α-ethynylestradiol- (E2-) induced gestationa...
Autores principales: | Chen, Wei, Gao, Xing-Xing, Ma, Li, Liu, Zhi-Bing, Li, Li, Wang, Hua, Gao, Lan, Xu, De-Xiang, Chen, Yuan-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885290/ https://www.ncbi.nlm.nih.gov/pubmed/31827696 http://dx.doi.org/10.1155/2019/7419249 |
Ejemplares similares
-
Obeticholic acid improves fetal bile acid profile in a mouse model of gestational hypercholanemia
por: Pataia, Vanessa, et al.
Publicado: (2020) -
FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis
por: van Golen, Rowan F., et al.
Publicado: (2018) -
Fetal gender and gestational age differentially affect PCSK9 levels in intrauterine growth restriction
por: Pecks, Ulrich, et al.
Publicado: (2016) -
The importance of fetal gender in intrauterine growth restriction
por: Radulescu, L, et al.
Publicado: (2013) -
Prevalence and risk factors of intrahepatic cholestasis of pregnancy in a Chinese population
por: Gao, Xing-Xing, et al.
Publicado: (2020)